These results align with a previous study conducted by Kiyota et al., where AAV-mediated FGF-2 delivery into the hippocampi of a murine AD model resulted in improved spatial learning and long-term potentiation [115]. This evidence concerns the gene FGF2 and Alzheimer disease.